AU2023203616A1 — Sodium bicarbonate in situ conversion driven transdermal delivery of amine drug
Assigned to Corium LLC · Expires 2023-07-06 · 3y expired
What this patent protects
Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided. See Fig. 7. WO 2018/022816 PCT/US2017/044049 50 -l- Example 2 040 40 -- Comparative Example 3 -C Comparative Example 4 X30 -…
USPTO Abstract
Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided. See Fig. 7. WO 2018/022816 PCT/US2017/044049 50 -l- Example 2 040 40 -- Comparative Example 3 -C Comparative Example 4 X30 -A- Comparative Example 5 220 S10 E 0 0 20 40 60 80 100 120 140 160 Time (hr) FIG. 7
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.